Global Terbinafine Hydrochloride Drug Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Terbinafine Hydrochloride Drug market report explains the definition, types, applications, major countries, and major players of the Terbinafine Hydrochloride Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Dr Reddy's Laboratories

    • Glenmark

    • TEVA

    • Breckenridge Pharmaceutical

    • Hubei Hengan Fulin Pharm

    • CIPLA LTD

    • Novartis

    • TARO

    • InvaGen Pharmaceuticals

    • Harris Pharmaceutical

    • GSK

    • Xiuzheng Pharmaceutical

    • Cussess

    • APOTEX

    • Jilin Wantong Group

    • Orchid Healthcare

    By Type:

    • Topical

    • Oral

    By End-User:

    • Athlete's Foot

    • Jock Itch

    • Ringworm

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Terbinafine Hydrochloride Drug Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Terbinafine Hydrochloride Drug Outlook to 2028- Original Forecasts

    • 2.2 Terbinafine Hydrochloride Drug Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Terbinafine Hydrochloride Drug Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Terbinafine Hydrochloride Drug Market- Recent Developments

    • 6.1 Terbinafine Hydrochloride Drug Market News and Developments

    • 6.2 Terbinafine Hydrochloride Drug Market Deals Landscape

    7 Terbinafine Hydrochloride Drug Raw Materials and Cost Structure Analysis

    • 7.1 Terbinafine Hydrochloride Drug Key Raw Materials

    • 7.2 Terbinafine Hydrochloride Drug Price Trend of Key Raw Materials

    • 7.3 Terbinafine Hydrochloride Drug Key Suppliers of Raw Materials

    • 7.4 Terbinafine Hydrochloride Drug Market Concentration Rate of Raw Materials

    • 7.5 Terbinafine Hydrochloride Drug Cost Structure Analysis

      • 7.5.1 Terbinafine Hydrochloride Drug Raw Materials Analysis

      • 7.5.2 Terbinafine Hydrochloride Drug Labor Cost Analysis

      • 7.5.3 Terbinafine Hydrochloride Drug Manufacturing Expenses Analysis

    8 Global Terbinafine Hydrochloride Drug Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Terbinafine Hydrochloride Drug Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Terbinafine Hydrochloride Drug Export by Region (Top 10 Countries) (2017-2028)

    9 Global Terbinafine Hydrochloride Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Terbinafine Hydrochloride Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Topical Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Oral Consumption and Growth Rate (2017-2022)

    • 9.2 Global Terbinafine Hydrochloride Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Athlete's Foot Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Jock Itch Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Ringworm Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Terbinafine Hydrochloride Drug Market Analysis and Outlook till 2022

    • 10.1 Global Terbinafine Hydrochloride Drug Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.2.2 Canada Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.2.3 Mexico Terbinafine Hydrochloride Drug Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.3.2 UK Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.3.3 Spain Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.3.4 Belgium Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.3.5 France Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.3.6 Italy Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.3.7 Denmark Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.3.8 Finland Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.3.9 Norway Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.3.10 Sweden Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.3.11 Poland Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.3.12 Russia Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.3.13 Turkey Terbinafine Hydrochloride Drug Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.4.2 Japan Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.4.3 India Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.4.4 South Korea Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.4.5 Pakistan Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.4.6 Bangladesh Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.4.7 Indonesia Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.4.8 Thailand Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.4.9 Singapore Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.4.10 Malaysia Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.4.11 Philippines Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.4.12 Vietnam Terbinafine Hydrochloride Drug Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.5.2 Colombia Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.5.3 Chile Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.5.4 Argentina Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.5.5 Venezuela Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.5.6 Peru Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.5.7 Puerto Rico Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.5.8 Ecuador Terbinafine Hydrochloride Drug Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.6.2 Kuwait Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.6.3 Oman Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.6.4 Qatar Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Terbinafine Hydrochloride Drug Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.7.2 South Africa Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.7.3 Egypt Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.7.4 Algeria Terbinafine Hydrochloride Drug Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Terbinafine Hydrochloride Drug Consumption (2017-2022)

      • 10.8.2 New Zealand Terbinafine Hydrochloride Drug Consumption (2017-2022)

    11 Global Terbinafine Hydrochloride Drug Competitive Analysis

    • 11.1 Dr Reddy's Laboratories

      • 11.1.1 Dr Reddy's Laboratories Company Details

      • 11.1.2 Dr Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Dr Reddy's Laboratories Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.1.4 Dr Reddy's Laboratories Terbinafine Hydrochloride Drug Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Glenmark

      • 11.2.1 Glenmark Company Details

      • 11.2.2 Glenmark Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Glenmark Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.2.4 Glenmark Terbinafine Hydrochloride Drug Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 TEVA

      • 11.3.1 TEVA Company Details

      • 11.3.2 TEVA Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 TEVA Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.3.4 TEVA Terbinafine Hydrochloride Drug Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Breckenridge Pharmaceutical

      • 11.4.1 Breckenridge Pharmaceutical Company Details

      • 11.4.2 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.4.4 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Hubei Hengan Fulin Pharm

      • 11.5.1 Hubei Hengan Fulin Pharm Company Details

      • 11.5.2 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.5.4 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 CIPLA LTD

      • 11.6.1 CIPLA LTD Company Details

      • 11.6.2 CIPLA LTD Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 CIPLA LTD Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.6.4 CIPLA LTD Terbinafine Hydrochloride Drug Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Novartis

      • 11.7.1 Novartis Company Details

      • 11.7.2 Novartis Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Novartis Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.7.4 Novartis Terbinafine Hydrochloride Drug Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 TARO

      • 11.8.1 TARO Company Details

      • 11.8.2 TARO Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 TARO Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.8.4 TARO Terbinafine Hydrochloride Drug Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 InvaGen Pharmaceuticals

      • 11.9.1 InvaGen Pharmaceuticals Company Details

      • 11.9.2 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.9.4 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Harris Pharmaceutical

      • 11.10.1 Harris Pharmaceutical Company Details

      • 11.10.2 Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Harris Pharmaceutical Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.10.4 Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 GSK

      • 11.11.1 GSK Company Details

      • 11.11.2 GSK Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 GSK Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.11.4 GSK Terbinafine Hydrochloride Drug Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Xiuzheng Pharmaceutical

      • 11.12.1 Xiuzheng Pharmaceutical Company Details

      • 11.12.2 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.12.4 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Cussess

      • 11.13.1 Cussess Company Details

      • 11.13.2 Cussess Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Cussess Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.13.4 Cussess Terbinafine Hydrochloride Drug Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 APOTEX

      • 11.14.1 APOTEX Company Details

      • 11.14.2 APOTEX Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 APOTEX Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.14.4 APOTEX Terbinafine Hydrochloride Drug Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Jilin Wantong Group

      • 11.15.1 Jilin Wantong Group Company Details

      • 11.15.2 Jilin Wantong Group Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Jilin Wantong Group Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.15.4 Jilin Wantong Group Terbinafine Hydrochloride Drug Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Orchid Healthcare

      • 11.16.1 Orchid Healthcare Company Details

      • 11.16.2 Orchid Healthcare Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Orchid Healthcare Terbinafine Hydrochloride Drug Main Business and Markets Served

      • 11.16.4 Orchid Healthcare Terbinafine Hydrochloride Drug Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    12 Global Terbinafine Hydrochloride Drug Market Outlook by Types and Applications to 2028

    • 12.1 Global Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Topical Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Athlete's Foot Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Jock Itch Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Ringworm Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Terbinafine Hydrochloride Drug Market Analysis and Outlook to 2028

    • 13.1 Global Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.2.2 Canada Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.3.2 UK Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.3.3 Spain Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.3.5 France Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.3.6 Italy Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.3.8 Finland Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.3.9 Norway Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.3.11 Poland Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.3.12 Russia Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.4.2 Japan Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.4.3 India Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.5.3 Chile Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.5.6 Peru Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.6.3 Oman Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Terbinafine Hydrochloride Drug Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Terbinafine Hydrochloride Drug

    • Figure of Terbinafine Hydrochloride Drug Picture

    • Table Global Terbinafine Hydrochloride Drug Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Terbinafine Hydrochloride Drug Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Topical Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Athlete's Foot Consumption and Growth Rate (2017-2022)

    • Figure Global Jock Itch Consumption and Growth Rate (2017-2022)

    • Figure Global Ringworm Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Terbinafine Hydrochloride Drug Consumption by Country (2017-2022)

    • Table North America Terbinafine Hydrochloride Drug Consumption by Country (2017-2022)

    • Figure United States Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Canada Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Mexico Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Terbinafine Hydrochloride Drug Consumption by Country (2017-2022)

    • Figure Germany Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure UK Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Spain Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Belgium Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure France Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Italy Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Denmark Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Finland Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Norway Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Sweden Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Poland Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Russia Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Turkey Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Table APAC Terbinafine Hydrochloride Drug Consumption by Country (2017-2022)

    • Figure China Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure India Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Thailand Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Singapore Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Philippines Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Table South America Terbinafine Hydrochloride Drug Consumption by Country (2017-2022)

    • Figure Brazil Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Colombia Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Chile Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Argentina Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Peru Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Table GCC Terbinafine Hydrochloride Drug Consumption by Country (2017-2022)

    • Figure Bahrain Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Oman Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Qatar Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Table Africa Terbinafine Hydrochloride Drug Consumption by Country (2017-2022)

    • Figure Nigeria Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure South Africa Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Egypt Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure Algeria Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Table Oceania Terbinafine Hydrochloride Drug Consumption by Country (2017-2022)

    • Figure Australia Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Terbinafine Hydrochloride Drug Consumption and Growth Rate (2017-2022)

    • Table Dr Reddy's Laboratories Company Details

    • Table Dr Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy's Laboratories Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table Dr Reddy's Laboratories Terbinafine Hydrochloride Drug Product Portfolio

    • Table Glenmark Company Details

    • Table Glenmark Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glenmark Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table Glenmark Terbinafine Hydrochloride Drug Product Portfolio

    • Table TEVA Company Details

    • Table TEVA Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table TEVA Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table TEVA Terbinafine Hydrochloride Drug Product Portfolio

    • Table Breckenridge Pharmaceutical Company Details

    • Table Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio

    • Table Hubei Hengan Fulin Pharm Company Details

    • Table Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Portfolio

    • Table CIPLA LTD Company Details

    • Table CIPLA LTD Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table CIPLA LTD Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table CIPLA LTD Terbinafine Hydrochloride Drug Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table Novartis Terbinafine Hydrochloride Drug Product Portfolio

    • Table TARO Company Details

    • Table TARO Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table TARO Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table TARO Terbinafine Hydrochloride Drug Product Portfolio

    • Table InvaGen Pharmaceuticals Company Details

    • Table InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Portfolio

    • Table Harris Pharmaceutical Company Details

    • Table Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Harris Pharmaceutical Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio

    • Table GSK Company Details

    • Table GSK Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table GSK Terbinafine Hydrochloride Drug Product Portfolio

    • Table Xiuzheng Pharmaceutical Company Details

    • Table Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio

    • Table Cussess Company Details

    • Table Cussess Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cussess Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table Cussess Terbinafine Hydrochloride Drug Product Portfolio

    • Table APOTEX Company Details

    • Table APOTEX Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table APOTEX Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table APOTEX Terbinafine Hydrochloride Drug Product Portfolio

    • Table Jilin Wantong Group Company Details

    • Table Jilin Wantong Group Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jilin Wantong Group Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table Jilin Wantong Group Terbinafine Hydrochloride Drug Product Portfolio

    • Table Orchid Healthcare Company Details

    • Table Orchid Healthcare Terbinafine Hydrochloride Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Orchid Healthcare Terbinafine Hydrochloride Drug Main Business and Markets Served

    • Table Orchid Healthcare Terbinafine Hydrochloride Drug Product Portfolio

    • Figure Global Topical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Athlete's Foot Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Jock Itch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ringworm Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Terbinafine Hydrochloride Drug Consumption Forecast by Country (2022-2028)

    • Table North America Terbinafine Hydrochloride Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Terbinafine Hydrochloride Drug Consumption Forecast by Country (2022-2028)

    • Figure Germany Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Terbinafine Hydrochloride Drug Consumption Forecast by Country (2022-2028)

    • Figure China Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Terbinafine Hydrochloride Drug Consumption Forecast by Country (2022-2028)

    • Figure Brazil Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Terbinafine Hydrochloride Drug Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Terbinafine Hydrochloride Drug Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Terbinafine Hydrochloride Drug Consumption Forecast by Country (2022-2028)

    • Figure Australia Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Terbinafine Hydrochloride Drug Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.